Growing community of inventors

Yongin-si, South Korea

Ku Suk Kang

Average Co-Inventor Count = 6.63

ph-index = 1

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 2

Ku Suk KangSang Ku Yoo (7 patents)Ku Suk KangJi Young Kim (6 patents)Ku Suk KangJeong Ho Im (6 patents)Ku Suk KangJin Young Kim (5 patents)Ku Suk KangJin Wook Chung (5 patents)Ku Suk KangIn Geun Jo (5 patents)Ku Suk KangJung Woo Lee (2 patents)Ku Suk KangJin Sung Kim (1 patent)Ku Suk KangJin Young Kim (3 patents)Ku Suk KangJeong Ho Lim (1 patent)Ku Suk KangJi Young Kim (0 patent)Ku Suk KangJin Wook Chung (0 patent)Ku Suk KangKu Suk Kang (7 patents)Sang Ku YooSang Ku Yoo (8 patents)Ji Young KimJi Young Kim (82 patents)Jeong Ho ImJeong Ho Im (6 patents)Jin Young KimJin Young Kim (34 patents)Jin Wook ChungJin Wook Chung (10 patents)In Geun JoIn Geun Jo (7 patents)Jung Woo LeeJung Woo Lee (2 patents)Jin Sung KimJin Sung Kim (87 patents)Jin Young KimJin Young Kim (3 patents)Jeong Ho LimJeong Ho Lim (1 patent)Ji Young KimJi Young Kim (0 patent)Jin Wook ChungJin Wook Chung (0 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Glaceum, Inc. (7 from 7 patents)


7 patents:

1. 12486282 - Method for synthesizing 2-((6-(hydroxymethyl)chromene-5-yl)oxy)-1-phenylethanone derivative

2. 11420988 - Catalyst for asymmetric hydrogenation of compound containing carbon double bond

3. 11420978 - Method for synthesizing 3-phenyl-2,8-dihydropyrano [2,3-f] chromene derivative

4. 11332475 - Optically active pyranochromenyl phenol derivative and pharmaceutical composition comprising same

5. 10947250 - 3-phenyl-2,3,4,8,9,10-hexahydropyrano[2,3-f]chromene derivative and method for synthesizing optical isomer thereof

6. 10669282 - Method for synthesizing 3-phenyl-2,3,4,8,9,10-hexahydropyrano[2.3-f]chromene derivative and optical isomer of thereof

7. 9783551 - Pyranochromenyl phenol derivative, and pharmaceutical composition for treating metabolic syndrome or inflammatory disease

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/8/2025
Loading…